Allucent

Gold Sponsor

Allucent, is a global clinical services organization uniquely positioned to serve small and mid-sized biotech companies. With more than 30 years of experience in over 60 countries, we have supported over 210 rare and orphan disease clinical studies across a variety of novel therapy classes and precision medicine including; gene therapies, GMO’s, stem cell therapies, and mRNA and antisense therapies.

From natural history studies to pivotal trials, our expertise includes complex clinical trial considerations such as pediatric patient populations, new biomarkers, surrogate endpoints, and the incorporation of patient perspectives and experiences, across a wide range of innovative medicines and advanced therapeutics in rare and ultra-rare diseases.

We maintain specialized staff with deep expertise in rare disease research as well as experience working with regulators in the U.S., EU, and beyond. With an integrated approach encompassing regulatory, clinical, and scientific expertise, we’re adept at overcoming the challenges of delivering novel treatments to patients.

Visit our website for further information, www.allucent.com

website